November 2025 in “EXPERIMENTAL ANIMALS” In this murine study, researchers found that topical treatment with Philippine stingless bee propolis increased folliculogenesis, epidermal thickness, and melanogenesis, but not hair length, potentially supporting hair follicle regeneration and melanocyte function in chemotherapy-induced alopecia models.
June 2021 in “Current Biochemistry” This study determined that a 6.25% concentration of propolis effectively inhibits the growth of dandruff-causing bacteria, with effectiveness values of 223.52% and 99.59% compared to ketoconazole and another propolis extract, respectively.
2 citations
,
October 2022 in “Jikken Dobutsu” This study found that Philippines stingless bee propolis extract promotes hair growth in mice by activating the Wnt/β-catenin signaling pathway and stimulating hair follicle development.
September 2014 in “Archives of disease in childhood” This case report describes a 12-year-old boy who developed severe shingles with skin erosion and hair loss despite early aciclovir treatment after a stem-cell transplant for relapsed acute myeloid leukemia.
54 citations
,
June 1990 in “Journal of The American Academy of Dermatology” This review discusses various skin infections and conditions that commonly occur in patients with HIV, but it does not report new research findings.
32 citations
,
January 2012 in “International Journal of Dermatology” This study reported that the most common skin side effect of epidermal growth factor receptor inhibitors was a papulopustular rash, treatable with symptom-targeted therapies, while drug suspension was rarely needed.
28 citations
,
October 2000 in “International Journal of Dermatology” This case report details a 37-year-old man who developed eosinophilic pustular dermatosis after previously resolving herpes zoster, with successful treatment using itraconazole and cycloproxolamine.
25 citations
,
November 2022 in “British journal of dermatology/British journal of dermatology, Supplement” In this analysis, safety data from two clinical trials showed that baricitinib for severe alopecia areata had predictable side effects like infections and elevated CPK, with some serious adverse events noted at low incidence rates; no deaths were reported.
25 citations
,
December 1995 in “Neurology” This study observed that in varicella, the varicella-zoster virus spreads to dermal endothelial cells before reaching keratinocytes, whereas in herpes zoster, it first involves cutaneous nerves and pilosebaceous units.
24 citations
,
June 2016 in “Acta dermato-venereologica” In this case report, tofacitinib was associated with new hair growth on psoriasis lesions after three months of treatment.
21 citations
,
June 2020 in “Dermatologic Therapy” This study found a marked decrease in dermatology outpatient visits during the initial two months of COVID-19, with shifts in diagnosis frequencies for conditions like generalized pruritus and alopecia areata.
16 citations
,
December 2020 in “International Journal of Clinical Practice” This study found that urticaria, psoriasis, and allergic/irritant contact dermatitis were more commonly diagnosed during the COVID-19 pandemic period, while acne and some other dermatological conditions decreased compared to before the pandemic.
10 citations
,
February 2006 in “Archives of dermatology” A man's chest hair turned white after a shingles infection, possibly due to virus-damaged pigment cells.
6 citations
,
September 2010 in “Archives of Dermatology” This case study suggests that thermography could objectively assess pain severity in herpes zoster patients by correlating thermal images with reported pain intensity.
4 citations
,
January 2009 in “Indian Journal of Dermatology, Venereology and Leprology” This archived website overview discusses Bioline International's role in reducing the knowledge gap by hosting peer-reviewed journals from developing countries but presents no new research findings.
3 citations
,
August 2023 in “Clinical Cosmetic and Investigational Dermatology” This case report details an instance of Wolf's isotopic response, where a 76-year-old patient developed keloids at the site of a previous herpes zoster infection, highlighting the unclear pathogenesis and theoretical explanations for such occurrences.
3 citations
,
January 2023 in “Indian Dermatology Online Journal” This study reported a series of mild to moderate cutaneous adverse drug reactions following COVID-19 vaccination, predominantly after Covishield, with only one requiring hospitalization.
3 citations
,
June 2022 in “Journal of The American Academy of Dermatology” In this study, the COVID-19 pandemic was associated with increased diagnoses of acne and telogen effluvium, particularly among patients with COVID-19, at a New York City hospital system.
3 citations
,
May 2010 in “Archives of dermatology” This excerpt discusses website navigation and access details for JAMA Dermatology and reports no new research findings.
3 citations
,
January 2008 in “Journal of the American Academy of Dermatology” A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.
3 citations
,
April 2002 in “The Lancet” In this case report, the authors identified giant cell arteritis as the underlying cause of bitemporal hair loss and scalp tenderness in a 70-year-old woman, initially misdiagnosed as age-related symptoms.
2 citations
,
December 2019 in “Chinese medical journal/Chinese Medical Journal” This case report describes a rare instance of tinea capitis caused by Trichophyton tonsurans in a Chinese patient, followed by the development of herpes zoster, suggesting a potential link to immunosuppression.
2 citations
,
January 2012 in “PubMed” This study found that mycophenolate mofetil is effective for both induction and maintenance therapy in children with severe lupus nephritis, significantly improving proteinuria and antibody levels, without renal flares during maintenance.
1 citations
,
January 2024 in “American journal of clinical and experimental immunology.” This study reports that cutaneous manifestations such as herpes zoster, purpura, and livedo reticularis in COVID-19 patients can potentially indicate disease severity, aiding in the prediction of the illness's progression and guiding dermatological management during the pandemic.
1 citations
,
October 2022 in “Current Dermatology Reports” This review discusses various skin reactions after SARS-CoV-2 infection and COVID-19 vaccination, noting a higher incidence with mRNA vaccines than adenovirus vector vaccines, and reports no new clinical results.
1 citations
,
February 2021 in “Cutis” This review discusses the various skin manifestations of COVID-19, aiming to improve early detection and treatment but reports no new clinical results.
August 2025 in “International Journal of Clinical Dermatology” In this study, a possible case of Wolf’s isotopic response was observed, where a 72-year-old woman developed superficial basal cell carcinoma at a prior herpes zoster site on her scalp, possibly due to altered local immunity from the zoster episode.
June 2025 in “Clinical Dermatology Review” This case study documents a rare concurrent presentation of herpes zoster and alopecia areata in a 24-year-old male, highlighting transient alopecia as a cutaneous complication of varicella zoster infection and suggesting further research into the virus's effect on dormant hair follicles.
In this case series, Xiang Chen reported instances of nail damage and hair loss following herpes zoster, noting the need for further exploration into the mechanisms and potential risk factors such as tuberculosis infection and kidney transplantation.
March 2024 in “IP Indian journal of clinical and experimental dermatology” In this study conducted at a tertiary care center, rural elderly patients often exhibited skin conditions like wrinkling, generalized pruritus, xerosis, eczematous skin conditions, and psoriasis, highlighting the need for better health education on skin care, early diagnosis, and management.